N.J., Nov. 6, 2026/PRNewswire/ –OnkosSurgical, Inc. today announced a new FDA 510(k) clearance for itsNanoCept® Antibacterial Technology, expanding its application to a broader offering of titanium components in theELEOS™ Limb Salvage System. This marks another milestone in the company’s continued investment in antibacterial innovation
